Sign in
4/A

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-17-041618

Options or other derivatives

  • Chief Executive Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SIMARD JOHN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-19 Exercise or conversion : show line 1 in the form Stock Option +75,000 $4.24 $318,000 75,000 D
Loading xslF345X03/doc4a.xml…